SQ Innovation's At-Home Treatment for Heart Failure Edema Shows Promising Results in Trial
SQ Innovation has announced the results of the SUBCUT HF II trial, which evaluated the efficacy and safety of Lasix ONYU, a subcutaneous formulation of furosemide, for treating edema in heart failure patients at home. The trial involved 172 patients, with 92 receiving at-home treatment and 80 receiving standard in-hospital intravenous diuretics. The study found that patients treated at home spent an average of four fewer days in the hospital compared to those receiving traditional care. The trial met its primary endpoint of reducing hospital days, demonstrating that at-home treatment is both effective and safe. The results were presented at the Heart Failure 2026 congress in Barcelona. 
